Duke Cancer Institute shared a post on LinkedIn:
“A new study led by DCI researchers offers important insights into that challenge in advanced prostate cancer and could help pave the way for more personalized treatment approaches in the future.”
Title: Genetic ancestry–concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer
Authors: Sean A. Piwarski, Lauren E. Howard, Morgan A. Paul, Nick Bachelder, Bonnie LaCroix, Angela Clayton, Donna Allen, Julie Kephart, Andrew J. Armstrong, Steven R. Patierno, Daniel J. George, Terry Hyslop, Jennifer A. Freedman
Read the Full Article on Cancer

Other posts about Duke Cancer Institute on OncoDaily.